Proteogenomics Research Institute for Systems Medicine

Analysis

Proteogenomics Research Institute for Systems Medicine is a registered charity in United States, based in San Diego, CA. It received its IRS tax-exemption ruling in January 2011, 15 years ago. Its declared purposes cover diseases, disorders and medical disciplines, which this site groups under health and saving lives. The IRS classifies it as a publicly supported organisation (donations from the general public) under section 501(c)(3), and contributions to it are listed as tax-deductible.

In the financial year ending June 2023, Proteogenomics Research Institute for Systems Medicine reported income of $6.6m and spending of $6.7m, spending 100% of its income. Across the 5 years on record, from June 2019 to June 2023, income grew from $4.8m to $6.6m (+40%), an average of +8.7% a year. The sharpest change came in the year to June 2020, when income rose by 26%. Over the whole period it spent 100% of the income it received.

Among 40,470 United States charities whose main cause is health and saving lives and that reported income, Proteogenomics Research Institute for Systems Medicine sits at the 81st percentile: it is larger than about 81% of them. Against every charity in United States with reported income it ranks in the 93rd percentile, and in the 94th percentile within CA. Charities of a similar size with the same main cause include Metropolitan Jewish Health System Foundation ($6.6m), Plymouth Community Ambulance Assn ($6.7m) and Warroad Care Center ($6.6m).

On its Form 990 for the period ending June 2023, revenue came from contributions and grants 100% of the total. Compensation of current officers, directors and key employees was $337k (5.1% of expenses). Other salaries and wages came to $2.2m. At year end it held assets of $1.8m against liabilities of $2.3m, net assets of -$532k. It reported 36 employees.

Data notes from the register: Spending has exceeded income in each of the last three reported years, so the charity has been drawing on reserves or other funds.